Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose

Peter Laverman, Adrienne H. Brouwers, Els Th. M. Dams, Wim J. G. Oyen, Gert Storm, Nico van Rooijen, Frans H. M. Corstens and Otto C. Boerman
Journal of Pharmacology and Experimental Therapeutics June 2000, 293 (3) 996-1001;
Peter Laverman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne H. Brouwers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Els Th. M. Dams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J. G. Oyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert Storm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nico van Rooijen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frans H. M. Corstens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto C. Boerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

This study describes the effect of the lipid dose of99mTc-polyethylene glycol (PEG) liposomes in the low-dose range (0.02–1.0 μmol/kg) on the pharmacokinetics and biodistribution in rats, rabbits, and humans. The biodistribution and pharmacokinetics of 99mTc-PEG liposomes at various dose levels were studied in rats and rabbits with a focalEscherichia coli infection. Scintigraphic images were recorded on a gamma camera. In addition, the role of macrophages in the biodistribution of a low-dose PEG liposome injection was studied. Finally, the pharmacokinetics of 99mTc-PEG liposomes at two lipid dose levels was studied in four patients. At a dose level of 0.03 μmol/kg, the blood level in rats at 4 h postinjection was significantly lower than at the highest dose level (1.1 μmol/kg). The same effect was observed in rabbits where enhanced clearance was observed at a dose level of 0.02 μmol/kg. The circulatory half-life decreased from 10.4 to 3.5 h (at 1.0 and 0.02 μmol/kg, respectively). At the lowest dose level, liposomes were mainly taken up by the liver and to a lesser extent by the spleen. Injection of a low dose of PEG liposomes in macrophage-depleted rabbits resulted in normal pharmacokinetics, suggesting involvement of macrophages in the effectuation of the rapid elimination of the liposomes from the circulation. Most importantly, the rapid clearance of low-dose PEG liposomes was also observed in humans when relatively low lipid doses were administered. This study showed that at very low lipid doses the biodistribution of PEG liposomes is dramatically altered.

Footnotes

  • Send reprint requests to: Peter Laverman, University Medical Center Nijmegen, Department of Nuclear Medicine, P.O. Box 9101, NL-6500 HB Nijmegen, the Netherlands. E-mail:p.laverman{at}nugen.azn.nl

  • ↵1 This study was supported by Grant NGN 55.3665 from the Technology Foundation (Technologiestichting STW), the Netherlands.

  • Abbreviations:
    %ID
    percentage of injected dose
    PEG
    polyethylene glycol
    p.i.
    post injection
    MPS
    mononuclear phagocyte system
    HYNIC
    hydrazinonicotinamide
    DSPE
    distearoylphosphatidyl-ethanolamine
    PHEPC
    partially hydrogenated egg phosphatidyl choline
    • Received October 11, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 293 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 293, Issue 3
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose

Peter Laverman, Adrienne H. Brouwers, Els Th. M. Dams, Wim J. G. Oyen, Gert Storm, Nico van Rooijen, Frans H. M. Corstens and Otto C. Boerman
Journal of Pharmacology and Experimental Therapeutics June 1, 2000, 293 (3) 996-1001;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Preclinical and Clinical Evidence for Disappearance of Long-Circulating Characteristics of Polyethylene Glycol Liposomes at Low Lipid Dose

Peter Laverman, Adrienne H. Brouwers, Els Th. M. Dams, Wim J. G. Oyen, Gert Storm, Nico van Rooijen, Frans H. M. Corstens and Otto C. Boerman
Journal of Pharmacology and Experimental Therapeutics June 1, 2000, 293 (3) 996-1001;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Transport Is Not Rate-Limiting in Morphine Glucuronidation in the Single-Pass Perfused Rat Liver Preparation
  • Enhanced Hepatic Uptake and Bioactivity of Type α1(I) Collagen Gene Promoter-Specific Triplex-Forming Oligonucleotides after Conjugation with Cholesterol
  • Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
Show more ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics